Abstract
Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes in pregnant women and it’s prevalence is increasing worldwide. A total 100 cases of GDM and 100 healthy controls were included in a study and blood samples were collected in plain vials from all study participant. Difference among several variables which included BMI, glycemia, insulinaemia, HbA1c, total cholesterol, triglycerides, urinary albumin were compared between GDM cases and controls and were found to be statistically significant (p < 0.0001). Additionally, GDM cases showed 4.0 fold increase in miRNA-19a and 4.7 mean increase in miRNA-19b expression compared to healthy control individuals. A positive correlation was observed between miRNA-19a and miRNA-19b among GDM cases. However the correlation coefficient was 0.13 between miRNA-19a and miRNA-19b. This suggested that with the increase in miRNA-19a, miRNA-19b also increased. The findings of this study concludes that an increase in microRNA-19a and microRNA-19b is observed in GDM cases and could be linked with increased risk factor for worsening of the disease. MicroRNA-19a and 19b have been linked to alcoholism and smoking and could also be the factors in GDM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cao Y-L, Jia Y-J, Xing B-H, Shi D-D, Dong X-J (2017) Plasma microRNA-16-5p, -17-5p and -20a-5p: novel diagnostic biomarkers for gestational diabetes mellitus. J Obstet Gynaecol Res 43:974–981
Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC et al (2013) Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes 6:491
Costantino S, Paneni F, Luscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37:572–576
Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S (2003) Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 19:259–270
Djelmis J, Pavic M, Mulliqi Kotori V, Pavlic Renar I, Ivanisevic M, Oreskovic S (2016) Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynaecol Obstet 135:250–254
El-Chaar D, Finkelstein SA, Tu X et al (2013) The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 35:224–233
Fehlmann T, Ludwig N, Backes C, Meese E, Keller A (2016) Distribution of microRNA biomarker candidates in solid tissues and body fluids. RNA Biol 13:1084–1088
International Diabetes Federation (2017) IDF diabetes atlas—across the globe. http://diabetesatlas.org/across-the-globe.html. Accessed 6 July 2018
Lai EC (2003) microRNAs: runts of the genome assert themselves. Curr Biol 13:R925–R936
Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787–798
Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leive A, Hod M et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682
Mitanchez D, Yzydorczyk C, Siddeek B, Boubred F, Benahmed M, Simeoni U (2015) The offspring of the diabetic mother-short- and long-term implications. Best Pract Res Clin Obstet Gynaecol 29:256–269
Pheiffer C, Dias S, Rheeder P, Adam S (2018) Decreased expression of circulating miR-20a-5p in south African women with gestational diabetes mellitus. Mol Diagn Ther 22:345–352
Poirier C, Desgagné V, Guérin R, Bouchard L (2017) MicroRNAs in pregnancy and gestational diabetes mellitus: emerging role in maternal metabolic regulation. Curr Diabetes Rep 17:35
Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91:827–887
Sebastiani G, Guarino E, Grieco GE, Formichi C, Poggi CD, Ceccarelli E, Dotta F (2017) Circulating microrna (mirna) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of mirna mir-330-3p. Front Endocrinol 8:345
Turchinovich A, Weiz L, Burwinkel B (2012) Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37:460–465
Wilczynska A, Bushell M (2015) The complexity of miRNA-mediated repression. Cell Death Differ 22:22–33
Yan J, Yang H (2014) Gestational diabetes mellitus, programing and epigenetics. J Matern Fetal Neonatal Med 27:1266–1269
Zhao Z, Moley KH, Gronowski AM (2013) Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem 46(10–11):953–960
Zhu Yanan, Tian Fei, Li Hailing, Zhou Youxia, Jiafeng Lu, Ge Qinyu, Zhu Yanan, Tian Fei, Li Hailing, Zhou Youxia, Jiafeng Lu, Ge Qinyu (2015a) Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynecol Obstet 130(1):49–53
Zhu Y, Tian F, Li H, Zhou Y, Lu J et al (2015b) Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet 130:49–53
Acknowledgements
Authors thanks to all participants who involved in study and given precious time and significant contribution to complete this research work.
Author information
Authors and Affiliations
Contributions
FW: sample collection and experimentation. XZ: data Analysis and writing. HZ: research plan, finalizing manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Obtained.
Rights and permissions
About this article
Cite this article
Wang, F., Zhang, X. & Zhou, H. Role of cell free microRNA-19a and microRNA-19b in gestational diabetes mellitus patients. 3 Biotech 9, 406 (2019). https://doi.org/10.1007/s13205-019-1952-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-019-1952-9